Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

LECO Supports New West Coast Metabolomics Center

Published: Monday, September 16, 2013
Last Updated: Monday, September 16, 2013
Bookmark and Share
The West Coast Metabolomics Center will receive access to the LECO Citius™ LC-HRT.

LECO Corporation has announced its support of the West Coast Metabolomics Center, a new high-tech consortium of research and service laboratories housed within the University of California, Davis, Genome Center.

As part of an agreement with LECO, the West Coast Metabolomics Center will receive access to the LECO Citius™ LC-HRT (High Resolution TOFMS) for applied research in metabolomics that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, cancer, and atherosclerosis.

Designed for complex sample analysis, LECO’s HRT instrumentation provides acquisition speeds of up to 200 spectra/second, mass resolution up to 100,000 FWHM, and mass accuracy less than 1 ppm.

The new center is under the direction of Dr. Oliver Fiehn, professor of molecular and cellular biology at UC Davis. A worldwide leader in metabolomics, Dr. Fiehn has utilized LECO instruments to analyze more than 50,000 samples for more than 520 projects and 80 different species over the past seven years.

The results have been the basis for many scientific papers, ranging from microbial products to plant and pre-clinical and clinical studies.

“LECO is known for its robust and sensitive instruments, and its great software capability for distinguishing closely eluting compounds,” said Dr. Fiehn. “We believe the Citius may solve urgent bottlenecks in metabolomics, specifically because in our field, we have highly complex mixtures of compounds!”

“This partnership demonstrates LECO’s renewed commitment to the advancement of metabolomics,” said Dr. Jeff Patrick, Director of Marketed Technology, LECO Separation Science.

Dr. Patrick continued, “We are honored that Dr. Fiehn and his team chose the Citius LC-HRT to be part of the West Coast Metabolomics Center, and we are excited about the implications their research will have on the treatment of certain diseases.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,700+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LECO Announces Special Events at ASMS
Company to host a series of events during the conference held at the America’s Center, Saint Louis, MO on May 31-June 4.
Tuesday, May 12, 2015
Metabolomics Symposium Scheduled for November 4 in Dallas
Event is sponsored by LECO, AB SCIEX, GERSTEL and UT Southwestern Medical Center.
Tuesday, October 22, 2013
LECO Announces Special Events at ASMS
Special events at the 61st ASMS Conference on Mass Spectrometry and Allied Topics, June 9-13 in Minneapolis.
Thursday, June 06, 2013
AB SCIEX and LECO Announces Co-marketing Agreement
Bundled solutions leverage the synergy between two technology leaders.
Wednesday, March 20, 2013
LECO and Genedata Collaborate on Mass Spectrometry Data Analysis
Efficient mass spectrometry data analysis capabilities now available to a broad range of pharmaceutical, industrial biotech, and life science companies.
Thursday, September 27, 2012
LECO Partners with the Joint Mass Spectrometry Centre
The LECO European Life Sciences and Chemical Analysis Centre is providing access to high resolution mass spectrometry instrumentation to the Joint Mass Spectrometry Centre.
Wednesday, August 22, 2012
LECO Corporation Opens New Separation Science R&D Facility
Newest addition of Michigan-the Elizabeth S. Warren Technical Centre.
Tuesday, June 05, 2012
LECO Opens Global Support Center
The new building will house its Service, Customer Training, and Consumables departments, as well as three mobile laboratories.
Wednesday, January 11, 2006
Scientific News
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
New Protein Cleanup Factors Found to Control Bacterial Growth
UMass Amherst researchers characterize previously mysterious proteolysis factors.
New Treatment for Obesity Developed
Researchers at the University of Liverpool, working with a global healthcare company, have helped develop a new treatment for obesity.
How Cell Growth Triggers Cell Division
Researchers in Jan Skotheim's lab have discovered a previously unknown mechanism that controls how large cells grow, an insight that could one day provide insight into attacking diseases such as cancer.
Metabolomic Platform Reveals Fundamental Flaw in Common Lab Technology
A new study led by scientists at The Scripps Research Institute (TSRI) shows that a technology used in thousands of laboratories, called gas chromatography mass spectrometry (GC-MS), fundamentally alters the samples it analyzes.
Newly Identified Biochemical Pathway Could Be Target for Insulin Control
Researchers at Duke Medicine and the University of Alberta are reporting the identification of a new biochemical pathway to control insulin secretion from islet beta cells in the pancreas, establishing a potential target for insulin control.
Dirty,Crusty Meals Fit for (Long-Dormant) Microbes
Researchers apply the latest analytical techniques to further our understanding of desert biocrusts.
CSI -- On The Metabolite's Trail
Bioinformaticians at the University of Jena make the most efficient search engine for molecular structures available online.
Developing a Breathalyzer-Type Low Blood Sugar Warning Device For Diabetes
A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes.
Identifying The 'Dimmer Switch' Of Diabetes
University of Alberta research gives new insight into what causes Type 2 diabetes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,700+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos